ArticleFrontiers in oncology2022

lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy.

Can Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.